InnoCare hits profit milestone, enters new phase with global expansion, strong pipeline
The innovative drugmaker’s newfound profitability marks its transition into a new stage characterized by stability and virtuous development cycles Key Takeaways: InnoCare posted an annual profit of 644 million yuan,…
Recent Articles
RELATED ARTICLES
-
Jacobio Pharma poised to turn a profit from precision cancer drugs
- China’s biopharma sector enters the New Year on a high
- Hong Kong to welcome world-leading siRNA company as Ribo launches its IPO
- A healthy return: drug spin-off nets Keymed up to $320 million
-
Kintor regeneration advances with new marketing partnership
9939.HK
